| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.79B | +48.5% |
| Cost of Revenue | $745.6M | +42.7% |
| Gross Profit | $1.05B | +53.0% |
| R&D Expense | $240.2M | +26.0% |
| SG&A Expense | $273.6M | +21.0% |
| Operating Income | $526.8M | +100.7% |
| Pre-tax Income | $524.9M | +92.8% |
| Income Tax | $87.3M | +189.0% |
| Net Income | $437.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288.6M | +52.5% |
| Short-term Investments | $449.3M | -16.2% |
| Accounts Receivable | $182.7M | +74.3% |
| Inventory | $447.3M | +72.4% |
| Current Assets | $1.41B | +25.4% |
| Total Assets | $2.06B | +29.8% |
| Current Liabilities | $263.4M | +16.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $246.7M | -22.9% |
| Capital Expenditures | $58.8M | -37.7% |
| Investing Cash Flow | -$12.5M | +96.7% |
| Financing Cash Flow | -$128.8M | -42.8% |
| Free Cash Flow | $187.8M | -16.7% |
| +80.8% |
| EPS (Basic) | $9.37 | +77.5% |
| EPS (Diluted) | $9.05 | +79.2% |
| Total Liabilities |
| $390.3M |
| +14.2% |
| Stockholders' Equity | $1.67B | +34.1% |